Teresa Amaral

Teresa Amaral, MD, PhD, is the Head of the Early Phase Clinical Trials and the Skin Cancer and Sarcoma Program at the ICANS, Strasbourg, France. Her research focuses on predictive biomarkers for systemic therapy in advanced melanoma and prognostic biomarkers in early-stage melanoma. She serves as Chair of the ESMO Leadership Development Committee and is a member of the ESMO Melanoma and Other Skin Tumours Faculty.